Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 32, 2018 - Issue 16
3,858
Views
191
CrossRef citations to date
0
Altmetric
Review

Natural products for human health: an historical overview of the drug discovery approaches

, , &
Pages 1926-1950 | Received 18 May 2017, Accepted 10 Jul 2017, Published online: 27 Jul 2017

References

  • Alejandro M, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, McIntosh JM, Newman DJ, Potts BC, Shuster DE. 2010. The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharm Sci. 31:255–265.
  • Allen DE, Hatfield G. 2004. Medicinal plants in folk tradition: An ethnobotany of Britain and Ireland. Cambridge: Timber Press.
  • Amirkia V, Heinrich M. 2014. Alkaloids as drug leads - a predictive structural and biodiversity-based analysis. Phytochem Lett. 10:48–53.
  • Appendino G, Fontana G, Pollastro F. 2010. Natural products drug discovery. In: Mander L, Liu HW, editors. Comprehensive natural products II. Oxford: Elsevier; p. 205–236.10.1016/B978-008045382-8.00064-2
  • Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, et al. 2015. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. 33:1582–1614.10.1016/j.biotechadv.2015.08.001
  • Baker DD, Chu M, Oza U, Rajgarhia V. 2007. The value of natural products to future pharmaceutical discovery. Nat Prod Rep. 24:1225–1244.10.1039/b602241n
  • Baltz RH. 2006. Marcel faber roundtable: is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration? J Ind Microbiol Biotechnol. 33:507.10.1007/s10295-005-0077-9
  • Balunas MJ, Su B, Landini S, Brueggemeier RW, Kinghorn AD. 2006. Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay. J Nat Prod. 69:700–703.10.1021/np050513p
  • Baslow MH. 1969. A study of toxins and other biologically active substances of marine origin. In: Williams L, Wilkins, editors. Marine pharmacology. Baltimore (MD): Krieger Publishing Company.
  • Bauer RA, Wurst JM, Tan DS. 2010. Expanding the range of ‘druggable’ targets with natural product-based libraries: an academic perspective. Curr Opin Chem Biol. 14:308–314.10.1016/j.cbpa.2010.02.001
  • Beith M. 1995. Healing threads: traditional medicines of the highlands and islands Edinburgh. Edinburgh: Polygon.
  • Benabdelaziz I, Marcout L, Benkhaled M, Wolfender JL, Haba H. 2017. Antioxidant and antibacterial activities and polyphenolic constituents of helianthemum sessiliflorum pers. Nat Prod Res. 6:686–690.10.1080/14786419.2016.1209669
  • Benamar H, Tomassini L, Venditti A, Marouf A, Bennaceur Serafini M, Nicoletti M. 2017. Acetylcholinesterase inhibitory activity of pyrrolizidine alkaloids from Echium confusum Coincy. Nat Prod Res. 11:1277–1285.10.1080/14786419.2016.1242000
  • Berenbaum MC. 1989. What is synergy? Pharmacol Rev. 41:93–141.
  • Beutler JA. 2009. Natural products as a foundation for drug discovery. Curr Protoc Pharmacol. 46:9.11.1–9. 11.21.
  • Bhakuni DS, Rawat DS. 2005. Bioactive Marine Natural Products. New Delhi, India: Springer and Anamaya Publishers.
  • Bhatnagar I, Se-Kwon K. 2010. Marine antitumor drugs: status, shortfalls and strategies. Mar Drugs. 8:2702–2720.10.3390/md8102702
  • Borchardt JK. 2002. The beginnings of drug therapy: ancient mesopotamian medicine. Drug News Perspect. 15:187–192.10.1358/dnp.2002.15.3.840015
  • Borlase W. 1758. The natural history of cornwall. Oxford: E & W Books.
  • Bostock W. 2002. To the limits of acceptability: political control of higher education. In: Biggs J, Davis R, editors. The subversion of Australian university. Wollongong (NSW): Fund for Intellectual Dissent; p. 20–40.
  • Brown G, Smale TC, King TJ, Hasenkamp R, Thompson RH. 1976. Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum. J Chem Soc Perkin Trans. 1:1165–1170.10.1039/p19760001165
  • Bruneton J. 2009. Pharmacognosie, phytochimie, plantes medicinales [Pharmacognosy, phytochemistry, medicinal plants]. Paris: Tec & Doc. Lavoisier.
  • Bucar F, Wube A, Schmid M. 2013. Natural product isolation - how to get from biological material to pure compounds. Nat Prod Rep. 30:525–545.10.1039/c3np20106f
  • Buriani A, Garcia-Bermejo ML, Bosisio E, Xu Q, Li H, Dong X, Simmonds MS, Carrara M, Tejedor N, Lucio-Cazana J, Hylsands PJ. 2012. Omic techniques in systems biology approaches to traditional Chinese medicine research: Present and future. J Ethnopharmacol. 140:535–544.10.1016/j.jep.2012.01.055
  • Burton G, Evans-Illidge EA. 2014. Emerging R and D law: the Nagoya protocol and its implications for researchers. ACS Chem Biol. 9:588–591.10.1021/cb500045t
  • Buss AD, Waigh RD. 1995. Antiparasitic drugs. In: Wolff ME, editor. Burger’s medicinal chemistry and drug discovery. New York (US): Wiley-Interscience; p. 1021–1028.
  • Butler MS. 2004. The role of natural product chemistry in drug discovery. J Nat Prod. 67:2141–2153.10.1021/np040106y
  • Cameron J. 1900. The gaelic names of plants (Scottish, Irish and Manx) collected and arranged in scientific order, with notes on their etymology, uses, plant superstitions, etc, among the celts, with copious gaelic, English and scientific indices. Glasgow: John Mackay.
  • Cannas S, Usai D, Tardugno R, Benvenuti S, Pellati F, Zanetti S, Molicotti P. 2016. Chemical composition, cytotoxicity, antimicrobial and antifungal activity of several essential oils. Nat Prod Res. 3:332–339.10.1080/14786419.2015.1060592
  • Canter PH, Thomas H, Ernst E. 2005. Bringing medicinal plants into cultivation: opportunities and challenges for biotechnology. Trends Biotechnol. 23:180–185.10.1016/j.tibtech.2005.02.002
  • Chen ST, Dou J, Temple R, Agarwal R, Wu KM, Walker S. 2008. New therapies from old medicines. Nat Biotechnol. 26:1077–1083.10.1038/nbt1008-1077
  • Chen CH, Dickman KG, Moriya M, Zavadil J, Sidorenko VS, Edwards KL, Gnatenko DV, Wu L, Turesky RJ, Wu XR, et al. 2012. Aristolochic acid-associated urothelial cancer in Taiwan. Proc Natl Acad Sci. 109:8241–8246.10.1073/pnas.1119920109
  • Clardy J, Walsh C. 2004. Lessons from natural molecules. Nature. 432:829–837.10.1038/nature03194
  • Coan KE, Ottl J, Klumpp M. 2011. Non-stoichiometric inhibition in biochemical high-throughput screening. Expert Opin Drug Discovery. 6:405–417.10.1517/17460441.2011.561309
  • Colegate SM, Molyneux RJ. 2008. Bioactive natural products: detection, isolation and structure determination. Boca Raton (FL): CRC Press. Chapter 16, Bioassay-Directed Isolation and Identification of Antiaflatoxigenic Constituents of Walnuts; p. 421–437.
  • Cordell GA. 2011. Sustainable medicines and global health care. Planta Med. 77:1129–1138.10.1055/s-0030-1270731
  • Corson TW, Crews CM. 2007. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell. 130:769–774.10.1016/j.cell.2007.08.021
  • Cragg GM. 1998. Paclitaxel (Taxol): a success story with valuable lessons for natural product drug discovery and development. Med Res Rev. 18:315–331.10.1002/(ISSN)1098-1128
  • Cragg GM, Newman DJ. 2005. Biodiversity: a continuing source of novel drug leads. Pure Appl Chem. 77:7–24.
  • Cragg GM, Newman DJ. 2013. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 1830:3670–3695.10.1016/j.bbagen.2013.02.008
  • Cragg GM, Schepartz SA, Suffness M, Grever MR. 1993. The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. J Nat Prod. 56:1657–1668.10.1021/np50100a001
  • Cragg GM, Katz F, Newman DJ, Rosenthal J. 2012. The impact of the United Nations Convention on Biological Diversity on natural products research. Nat Prod Rep. 29:1407–1423.10.1039/c2np20091 k
  • Cseke LJ, Kirakosyan A, Kaufmann PB, Warber SL, Duke JA, Brielmann HL. 2006. Natural products from plants. 2nd ed. Boca Raton (FL): CRC, Taylor and Francis.
  • Cuevas C, Francesch A. 2009. Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem. Nat Prod Rep. 26:322–337.10.1039/b808331m
  • David B, Wolfender JL, Dias DA. 2015. The pharmaceutical industry and natural products: historical status and new trends. Phytochem Rev. 14:299–315.10.1007/s11101-014-9367-z
  • Davies J. 1999. In praise of antibiotics. ASM News. 65:304–310.
  • Der Marderosian A, Beutler JA. 2002. The review of natural products. 3rd ed. St. Louis (MO): Facts and Comparisons.
  • Dewick PM. 2009. Medicinal natural products: a biosynthetic approach. 3rd ed. West Sussex: John Wiley & Sons.10.1002/9780470742761
  • Dias DA, Urban S, Roessner U. 2012. A historical overview of natural products in drug discovery. Metabolites. 2:303–336.10.3390/metabo2020303
  • Diblase L, Arrighi F, Silva J, Bardón A, Cartagena E. 2015. Penicillium commune metabolic profile as a promising source of antipathogenic natural products. Nat Prod Res. 23:2181–2187.10.1080/14786419.2015.1007457
  • Dickson M, Gagnon JP. 2004. The cost of new drug discovery and development. Discov Med. 4:172–179.
  • Duke JA, Duke PAK, du Cellier J. 2007. Duke’s handbook of medicinal plants of the Bible. Boca Raton (FL): CRC Press Taylor and Francis Group.10.1201/9780849382031
  • Eisenberg DM, Harris ES, Littlefield BA, Cao S, Craycroft JA, Scholten R, Bayliss P, Fu Y, Wang W, Qiao Y, et al. 2011. Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation - Rationale, methods and preliminary results from a Sino-American collaboration. Fitoterapia. 82:17–33.10.1016/j.fitote.2010.11.017
  • Elder AL. 1970. The History of Penicillin Production. J Pharm Sci. 56:1697.
  • El-Hossary EM, Cheng C, Hamed MM, El-Sayed Hamed AN, Ohlsen K, Hentschel U, Abdelmohsen UR. 2017. Antifungal potential of marine natural products. Eur J Med Chem. 126:631–651.10.1016/j.ejmech.2016.11.022
  • EMEA: European Agency for the Evaluation of Medicinal Products. 2006. Committee on herbal medicinal products (HMPC): guideline on good agricultural and collection practice for starting materials of herbal origin. London. EMEA/HMPC/246816/2005.
  • Endo A, Kuroda M, Tanzawa K. 1976. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett. 72:323.10.1016/0014-5793(76)80996-9
  • Erkens RHJ. 2011. What every chemist should know about plant names. Nat Prod Rep. 28:11–14.10.1039/C0NP00042F
  • Fabbretti A, Gualerzi CO, Brandi L. 2011. How to cope with the quest for new antibiotics. FEBS Lett. 585:1673–1681.10.1016/j.febslet.2011.04.029
  • Fabricant DS, Farnsworth NR. 2001. The value of plants used in traditionalmedicine for drug discovery. Environ Health Perspect. 109:69–75.10.1289/ehp.01109s169
  • Farnsworth NR. 1990. The role of ethnopharmacology in drug development. Ciba Found Symp. 154:2–11.
  • Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. 1985. Medicinal plants in therapy. Bull World Health Organ. 63:965–981.
  • Faulkner DJ. 1988. Marine natural products. Nat Prod Rep. 20:269–309.
  • FDA: Us Food and Drug Administration. 2015. New molecular entity (NME) drug and new biologic approvals. Available from https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/NDAandBLAApprovalReports/ucm373420.htm
  • Feher M, Schmidt JM. 2003. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci. 43:218–227.10.1021/ci0200467
  • Felter HW, Lloyd JU. 1898. King’s American dispensatory. 18th ed, 3th rev. Cincinnati, OH: Ohio Valley Co. Available from: https://wwwhenriettes-herbcom/eclectickings/index.html.
  • Fernando DR, Marshall AT, Forster PI, Hoebee SE, Siegele R. 2013. Multiple metal accumulation within a manganese-specific genus. Am J Bot. 100:690–700.10.3732/ajb.1200545
  • Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK. 2006. Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol. 2:458–466.10.1038/nchembio817
  • Fleming A. 1929. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ. Br J Exp Pathol. 10:226–236.
  • Gertsch J. 2011. Botanical drugs, synergy, and network pharmacology: forth and back to intelligent mixtures. Plant Med. 77:1086–1098.10.1055/s-0030-1270904
  • Gilbert N. 2010. Biodiversity law could stymie research. Nature. 463:598.10.1038/463598a
  • Gilbert N. 2012. Chinese herbal medicine breaks into EU market. https://blogs.nature.com/news/2012/04/chinese-herbal-medicine-breaks-into-eu-market.
  • Gleeson MP, Hersey A, Montanari D, Overington J. 2011. Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat Rev Drug Discov. 10:197–208.10.1038/nrd3367
  • Gou M, Wang L, Liu X. 2017. Anticoagulant activity of a natural protein purified from Hypomesus olidus. Nat Prod Res. 10:1168–1171.10.1080/14786419.2016.1222382
  • Gul S, Gribbon P. 2010. Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery. Expert Opin Drug Discovery. 5:681–690.10.1517/17460441.2010.495748
  • Haefner B. 2003. Drugs from the deep: marine natural products as drug candidates. Drug Discov Today. 8:536–544.10.1016/S1359-6446(03)02713-2
  • Harrison C. 2014. Patenting natural products just got harder. Nat Biotechnol. 32:403–404.10.1038/nbt0514-403a
  • Hassan SS, Shaikh AL. 2017. Marine actinobacteria as a drug treasure house. Biomed pharmacother. 87:46–57.10.1016/j.biopha.2016.12.086
  • Hatfield G. 2002. Country remedies: traditional east anglian plant remedies in the twentieth century. Woodbridge (UK): The Boydell Press.
  • He WJ, Zhou XJ, Qin XC, Mai YX, Lin XP, Liao SR, Yang B, Zhang T, Tu ZC, Wang JF, et al. 2017. Quinone/hydroquinone meroterpenoids with antitubercular and cytotoxic activities produced by the sponge-derived fungus Gliomastix sp. ZSDS1-F7. Nat Prod Res. 5:604–609.10.1080/14786419.2016.1207076
  • Heinrich M. 2010. Ethnopharmacology in the 21st century - grand challenges. Front Pharmacol. 1:8.
  • Heinrich M, Gibbons S. 2001. Ethnopharmacology in drug discovery: an analysis of its role and potential contribution. J Pharm Pharmacol. 53:425–432.10.1211/0022357011775712
  • Henrich CJ, Beutler JA. 2013. Matching the power of high throughput screening to the chemical diversity of natural products. Nat Prod Rep. 30:1284–1298.10.1039/c3np70052f
  • Henrich CJ, Bokesch HR, Dean M, Bates SE, Robey RW, Goncharova EI, Wilson JA, McMahon JB. 2006. A high-throughput cell-based assay for inhibitors of ABCG2 activity. J Biomol Screen. 11:176–183.10.1177/1087057105284576
  • Henríquez R, Faircloth G, Cuevas C. 2005. Ecteinascidin 743 (ET-743, Yondelis), aplidin, and kahalalide F. In: Cragg GM, Kingston DGI, Newman DJ, editors. Anticancer agents from natural products. Boca Raton (FL): Taylor and Francis.
  • Hermann JC, Chen Y, Wartchow C, Menke J, Gao L, Gleason SK, Haynes NE, Scott N, Petersen A, Gabriel, S, et al. 2013. Metal impurities cause false positives in high-throughput screening campaigns. ACS Med Chem Lett. 4:197–200.10.1021/ml3003296
  • Hicks S. 2014. Desert Plant and People. 1st ed. San Anatonio (TX): Naylor Co.
  • Hoffman F, Kishter SR. 2013. Botanical new drug applications - The Final Frontier. Herbalgram. 99:66–69.
  • Hosztafi S. 1997. The discovery of alkaloids. Pharmazie. 52:546–550.
  • Hunter P. 2008. Harnessing nature’s wisdom. Turning to nature for inspiration and avoiding her follies. EMBO Rep. 9:838–840.10.1038/embor.2008.160
  • International Union for Conservation of Nature (IUCN). 2015. Numbers of threatened species by major groups of organisms (1996–2015). Available from: https://cmsdocs.s3.amazonaws.com/summarystats/2015_2_Summary_Stats_Page_Documents/2015_2_RL_Stats_Table_1.pdf.
  • Ishitsuka MO, Kusumi TKH. 1988. Antitumor xenicane and norxenicane lactones from the brown alga Dictyota dichotoma. J Org Chem. 53:5010–5013.10.1021/jo00256a020
  • Johnson TA, Sohn J, Inman WD, Estee SA, Loveridge ST, Vervoort HC, Tenney K, Liu J, Ang KKH, Ratnam J, et al. 2011. Natural product libraries to accelerate the high-throughput discovery of therapeutic leads. J Nat Prod. 74:2545–2555.10.1021/np200673b
  • Jones WP, Kinghorn AD. 2012. Extraction of plant secondary metabolites. Methods Mol Biol. 864:341–366.
  • Kaiser H. 2008. Von der Pflanze zur Chemie - Die Frühgeschichte der “Rheumamittel”. [From the Plant to Chemistry - The Early History of the “Rheumamittel”]. Z Rheumatol. 67:252–262.10.1007/s00393-008-0257-x
  • Kamjam M, Sivalingam P, Deng Z, Hong K. 2017. Deep sea actinomycetes and their secondary metabolites. Front Microbiol. 8:760.10.3389/fmicb.2017.00760
  • Karlsdóttir A. 2016. The origin of FDA approved natural product new chemical entities [M. Sc. thesis in Pharmacy]. Faculty of Pharmaceutical Sciences, School of Health Sciences. University of Iceland.
  • Kerneis S, Swift LH, Lewis CW, Bruyére C, Oumata N, Colas P, Ruchaud S, Bain J, Golsteyn RM. 2015. Natural product extracts of the Canadian prairie plant, Thermopsis rhombifolia, have anti-cancer activity in phenotypic cell-based assays. Nat Prod Res. 11:1026–1034.10.1080/14786419.2014.979423
  • Kinghorn AD, Pan L, Fletcher JN, Chai H. 2011. The relevance of higher plants in lead compound discovery programs. J Nat Prod. 74:1539–1555.10.1021/np200391c
  • Kingston DG. 2011. Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod. 74:496–511.10.1021/np100550t
  • Klebe G. 2009. Wirkstoffdesign: Entwurf und Wirkung von Arzneistoffen [Drug design: design and effect of drugs]. 2nd ed. Springer Spektrum.10.1007/978-3-8274-2213-2
  • Koehn FE, Carter GT. 2005. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 4:206–220.10.1038/nrd1657
  • Kola I, Landis J. 2004. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov. 3:711–715.10.1038/nrd1470
  • van der Kooy F, Maltese F, Choi YH, Kim HK, Verpoorte R. 2009. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting. Planta Med. 75:763–775.10.1055/s-0029-1185450
  • Kusari S, Hertweck C, Spiteller M. 2012. Chemical ecology of endophytic fungi: origins of secondary metabolites. Chem Biol. 19:792–798.10.1016/j.chembiol.2012.06.004
  • Lamottke K, Ripoll C, Walczak R. 2011. The roots of innovation EBR. 15:52–56.
  • Lauro G, Masullo M, Piacente S, Riccio R, Bifulco C. 2012. Inverse virtual screening allows the discovery of the biological activity of natural compounds. Bioorg Med Chem. 20:3596–3602.10.1016/j.bmc.2012.03.072
  • Lawson K. 2013. Botanical and plant-derived drugs: Global markets. Wellesley: BCC Research.
  • Lax E. 2004. The mold in Dr Florey’s coat: The story of the penicillian miracle. New York (US): John Macrae/Henry Hol.
  • Lee ML, Schneider G. 2001. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J Comb Chem. 3:284–289.10.1021/cc000097 l
  • Li JW, Vederas JC. 2009. Drug discovery and natural products: end of an era or an endless frontier? Science. 325:161–165.10.1126/science.1168243
  • Lindequist U. 2016. Marine-derived pharmaceuticals – challenges and opportunities. Biomol Ther (Seoul). 24:561–571.10.4062/biomolther.2016.181
  • MacFarlane AM. 1929. Gaelic names of plants: Study of their uses and lore. Trans Gaelic Soc Inverness. 32:1–48.
  • Maes J, Verlooy L, Buenafe OE, deWitte PA, Esguerra CV, Crawford AD. 2012. Evaluation of 14 organic solvents and carriers for screening applications in zebrafish embryos and larvae. PLoS ONE. 7:e43850.10.1371/journal.pone.0043850
  • Maione F, Russo R, Khan H, Mascolo N. 2016. Medicinal plants with anti-inflammatory activities. Nat Prod Res. 12:1343–1352.10.1080/14786419.2015.1062761
  • Mann J. 1994. Murder, magic, and medicine. New York (NY): Oxford University Press.
  • Mann J. 1999. The elusive magic bullet: the search for the perfect drug. New York (NY): Oxford University Press.
  • Manzanares I, Cuevas C, Garcia-Nieto R, Marco E, Gago F. 2001. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anticancer agents. Curr Med Chem Anticancer Agents. 1:257.10.2174/1568011013354561
  • McChesney JD, Venkataraman SK, Henri JT. 2007. Plant natural products: back to the future or into extinction? Phytochemistry. 68:2015–22.10.1016/j.phytochem.2007.04.032
  • Mi Y, Zhang J, He S, Yan X. 2017. New peptides isolated form marine cyanobacteria, an oveview over the past decade. Mar Drugs. 15.
  • Miller JS. 2011. The discovery of medicines from plants: a current biological perspective. Econ Bot. 65:396–407.10.1007/s12231-011-9171-2
  • Mishra BB, Tiwari VK. 2011. Natural products: an evolving role in future drug discovery. Euro J Med Chem. 46:4769–4807.10.1016/j.ejmech.2011.07.057
  • Moloney MF. 1919. Irish ethno-botany and the evolution of medicine in Ireland. Dublin: MH Gill and Son.
  • Müller K. 2001. Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol. 56:9.
  • Naoghare PK, Song JM. 2010. Chip-based high throughput screening of herbal medicines. Comb Chem High Throughout Screen. 13:923–931.10.2174/138620710793360338
  • Newman DJ, Cragg GM. 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 75:311–335.10.1021/np200906s
  • Newman DJ, Cragg GM, Snader KM. 2003. Natural products as sources of new drugs over the period 1981−2002. J Nat Prod. 66:1022–1037.10.1021/np030096 l
  • Nicolaou KC, Yang Z, Liu JJ, Ueno H, Nantermet PG, Guy RK, Claiborne CF, Renaud J, Couladouros EA, Paulvannan K, Sorensen EJ. 1994. Total synthesis of taxol. Nature. 367:630–634.10.1038/367630a0
  • Nicoletti M. 2012. Nutraceuticals and botanicals: overview and perspectives. Int J Food Sci Nutr. 63:2–6.10.3109/09637486.2011.628012
  • Ó hEithir R. 1983. Folk medical beliefs and practices in the Aran Islands. Galway: National University of Ireland.
  • Oliva MJ. 2011. Sharing the benefits of biodiversity: a new international protocol and its implications for research and development. Planta Med. 77:1221–1227.10.1055/s-0031-1279978
  • Ortholand JY, Ganesan A. 2004. Natural products and combinatorial chemistry: back to the future. Curr Opin Chem Biol. 8:271–280.10.1016/j.cbpa.2004.04.011
  • Paterson I, Anderson EA. 2005. The renaissance of natural products as drug candidates. Science. 310:451–453.10.1126/science.1116364
  • Patwardhan B. 2005. Ethnopharmacology and drug discovery. J Ethnopharmacol. 100:50–52.10.1016/j.jep.2005.06.006
  • Purvis W. 2000. Lichens. London: The Natural History Museum.
  • Riaz M, Bilal A, Ali MS, Fatima I, Faisal A, Sherkheli MA, Asghar A. 2017. Natural products from Cuscuta reflexa Roxb. with antiproliferation activities in HCT116 colorectal cell lines. Nat Prod Res. 5:583–587.10.1080/14786419.2016.1198349
  • Ribnicky DM, Poulev A, Schmidt B, Cefalu WT, Raskin I. 2008. Evaluation of botanicals for improving human health. Am J Clin Nutr. 87:472S–475S.
  • Rinehart KL, Holt TG, Fregeau NL, Stroh JG, Keifer PA, Sun F, Li LH, Martin DG. 1990. Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. J Org Chem. 55:4512–4515.10.1021/jo00302a007
  • Rollinger JM. 2011. Combination of ethnopharmacological knowhow with modern in silico tools. Planta Med. 77:1230.
  • Rollinger JM, Langer T, Stuppner H. 2006. Strategies for efficient lead structure discovery from natural products. Curr Med Chem. 13:1491–1507.10.2174/092986706777442075
  • Sarasan M, Puthumana J, Job N, Han J, Lee JS, Philip R. 2017. Marine algicolous endophytic fungi – A promising drug resource of the era. J Microbiol Biotechnol.
  • Sarker SD, Latif Z, Gray AI. 2006. Methods in biotechnology: natural product isolation Satyajit DS. 2nd ed. Totowa (NJ): Human Press Inc.
  • Scannell JW, Blanckley A, Boldon H, Warrington B. 2012. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 11:191–200.10.1038/nrd3681
  • Scheinfeld N. 2008. Sinecatechins. Drugs Fut. 33:27–30.10.1358/dof.2008.033.01.1170146
  • Schmid II, Sattler II, Grabley S, Thiericke R. 1999. Natural products in high throughput screening: automated high-quality sample preparation. J Biomol Screen. 4:15–25.10.1177/108705719900400104
  • Schmidt B, Ribnicky DM, Poulev A, Logendra S, Cefalu WT, Raskin I. 2008. A natural history of botanical therapeutics. Metabolism. 57:S3–S9.10.1016/j.metabol.2008.03.001
  • Schmitt EK, Moore CM, Krastel P, Petersen F. 2011. Natural products as catalysts for innovation: a pharmaceutical industry perspective. Curr Opin Chem Biol. 15:497–504.10.1016/j.cbpa.2011.05.018
  • Sheridan C. 2012. Recasting natural product research. Nat Biotechnol. 30:385–387.10.1038/nbt.2208
  • Shults EE, Shakirov MM, Pokrovsky MA, Petrova TN, Pokrovsky AG, Gorovoy PG. 2017. Phenolic compounds from Glycyrrhiza pallidiflora maxim. and their cytotoxic activity. Nat Prod Res. 4:445–452.10.1080/14786419.2016.1188094
  • Sneader W. 2005. Drug discovery: a history. Chichester: John Wiley & Sons Ltd.10.1002/0470015535
  • Soejarto DD, Gyllenhaal C, Fong HH, Xuan LT, Hiep NT, Hung NV, Bich TQ, Southavong B, Sydara K, Pezzuto JM. 2004. The UIC ICBG (University of Illinois at Chicago International Cooperative Biodiversity Group) Memorandum of Agreement: a model of benefit-sharing arrangement in natural products drug discovery and development. J Nat Prod. 67(2):294–9.10.1021/np0304363
  • Stahura FL, Godden JW, Xue L, Bajorath J. 2000. Distinguishing between natural products and synthetic molecules by descriptor shannon entropy analysis and binary QSAR calculations. J Chem Inf Comput Sci. 40:1245–1252.10.1021/ci0003303
  • Stamets P. 2002. Novel antimicrobials from mushrooms herbal gram. 54:28–33.
  • Stickel F, Patsenker E, Schuppan D. 2005. Herbal hepatotoxicity. J Hepatol. 43:901–910.10.1016/j.jhep.2005.08.002
  • Swanton EW. 1915. Economic and folklore notes. Trans Br Mycol Soc. 5:408–409.
  • Swanton EW. 1932. Sussex County magazine. vol 6. Eastbourne: T.R.Beckett.
  • Thomas GL, Johannes CW. 2011. Natural product-like synthetic libraries. Curr Opin Chem Biol. 15:516–522.10.1016/j.cbpa.2011.05.022
  • Tringali C, Oriente G, Piattelli M, Geraci C, Nicolosi G, Breitmaier E. 1988. Crenuladial, an antimicrobial diterpenoid from the brown alga Dilophus ligulatus. Can J Chem. 66:2799–2802.10.1139/v88-432
  • Tu Y, Jeffries C, Ruan H, Nelson C, Smithson D, Shelat AA, Brown KM, Li XC, Hester JP, Smillie T, et al. 2010. An Automated high-throughput system to fractionate plant natural products for drug discovery. J Nat Prod. 73:751–754.10.1021/np9007359
  • Unschuld PU. 1986. Nan-ching the classic of difficult issues. Berkeley and Los Angeles (CA): University of California Press.
  • Verpoorte R. 2012. Good practices: the basis for evidencebased medicines. J Ethnopharmacol. 140:455–457.10.1016/j.jep.2012.02.033
  • Verpoorte R, Choi YH, Kim HK. 2005. Ethnopharmacology and system biology: a perfect holistic match. J Ethnopharmacol. 100:53–56.10.1016/j.jep.2005.05.033
  • Vickery R. 1995. A dictionary of plant-lore. Oxford: Oxford University Press.
  • Vines G. 2004. Herbal harvests with a future towards sustainable sources for medicinal plants. Salisbury: Plantlife International. Available from: https://www.plantlife.org.uk/uploads/ documents/Herbal-Harvests-with-a-Future.pdf.
  • Wagner H, Ulrich-Merzenich G. 2009. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 16:97–110.10.1016/j.phymed.2008.12.018
  • Wainwright M. 1990. Miracle Cure: The Story of Penicillin and the Golden Age of Antibiotics. Oxford (UK): Blackwell Scientific.
  • Wang M, Lamers R, Korthout H, van Nesselrooij Witikamp RF, van der Heijden R, Voshol PJ, Havekes LM, Verpoorte R, van der Greef J. 2005. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother Res. 19:173–182.10.1002/(ISSN)1099-1573
  • Wang T, Wu MB, Chen ZJ, Lin JP, Yang LR. 2016. Separation, determination and antifungal activity test of the products from a new Bacillus amyloliquefaciens. Nat Prod Res. 10:1215–1218.10.1080/14786419.2015.1048246
  • Watanabe K, Umeda K, Miyakado M. 1989. Isolation and identification of three insecticidal principles from the red alga Laurencia nipponica Yamada. Agric Biol Chem. 53:2513–2515.
  • WHO: World Health Organization. 2003. Guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva.
  • Williams JD. 1999. Beta-lactamases and beta-lactamase inhibitors. Int J Antimicrob Agents. 12:S2–S7.
  • Wright AE, Forleo DA, Gunawardana GP, Gunasekera SP, Koehn FE, McConnell OJ. 1990. Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian Ecteinascidia turbinata. J Org Chem. 55:4508–4512.10.1021/jo00302a006
  • Xie G, Li X, Li H, Jia W. 2013. Toward personalized nutrition: comprehensive phytoprofiling and metabotyping. J Proteome Res. 12:1547–1559.10.1021/pr301222b
  • Yang M, Poon J, Wang S, Jiao L, Poon S, Cui L, Chen P, Sze DMY, Xu L. 2013. Application of genetic algorithm for discovery of core effective formulae in TCM clinical data. Comp Math Methods in Medicine. 2013:1–16.
  • Yuliana ND, Khatib A, Choi YH, Verpoorte R. 2011. Metabolomics for bioactivity assessment of natural products. Phytother Res. 25:157–169.
  • Zenk MH, Juenger M. 2007. Evolution and current status of the phytochemistry of nitrogenous compounds. Phytochemistry. 68:2757–2772.10.1016/j.phytochem.2007.07.009
  • Zhang B, Peng Y, Zhang Z, Liu H, Qi Y, Liu S, Xiao P. 2010. GAP production of TCM herbs in China. Planta Med. 76:1948–1955.10.1055/s-0030-1250527
  • Zhang H, Dong M, Wang H, Crews P. 2017. Secondary Metabolites from the Marine Sponge Genus Phyllospongia. Mar Drugs. 15:12.10.3390/md15010012
  • Zhu M, Phillipson JD, Greengrass PM, Bowery NE, Cai Y. 1997. Plant polyphenols: biologically active compounds or non-selective binders to protein? Phytochemistry. 44:441–447.10.1016/S0031-9422(96)00598-5
  • Zhu F, Qin C, Tao L, Liu X, Shi Z, Ma X, Jia J, Tan Y, Cui C, Lin C, Tan C, Jiang Y, Chen Y. 2011. Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting. Proc Natl Acad Sci US. 108:12943–12948.10.1073/pnas.1107336108
  • Zou L, Harkey MR, Henderson GL. 2002. Effects of intrinsic fluorescence and quenching on fluorescence-based screening of natural products. Phytomedicine. 9:263–267.10.1078/0944-7113-00121

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.